Pulmonary alveolar proteinosis in workers at an indium processing facility.
暂无分享，去创建一个
[1] V. Roggli,et al. Pulmonary alveolar proteinosis in workers at an indium processing facility. , 2010, American journal of respiratory and critical care medicine.
[2] R. Borie,et al. Rituximab therapy in autoimmune pulmonary alveolar proteinosis , 2009, European Respiratory Journal.
[3] D. Lison,et al. Sintered indium-tin-oxide (ITO) particles: a new pneumotoxic entity. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[4] Y. Nishiwaki,et al. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage , 2007, Occupational and Environmental Medicine.
[5] T. Chonan,et al. Interstitial pulmonary disorders in indium-processing workers , 2006, European Respiratory Journal.
[6] K. Kishi,et al. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide , 2005, European Respiratory Journal.
[7] J. Whitsett,et al. Pulmonary alveolar proteinosis. , 2003, The New England journal of medicine.
[8] K. Sekizawa,et al. Interstitial Pneumonia Developed in a Worker Dealing with Particles Containing Indium‐tin Oxide , 2003, Journal of occupational health.
[9] A. Dunn,et al. Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis , 2003, Thorax.